Cel Sci (CVM) Inventory (2010 - 2026)
Cel Sci (CVM) posted Inventory of $281462.0 for Q1 2026, up 22.14% sequentially from $230448.0 in Q4 2025, and down 68.11% YoY from $882692.0 in Q1 2025.
Cel Sci (CVM) Inventory (2010 - 2026) Analysis & Trends
Cel Sci has reported Inventory for 16 years, with the latest figure at $281462.0 in Q1 2026.
- Quarterly Inventory fell 68.11% year-over-year to $281462.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $281462.0 (down 68.11% YoY) and the FY2025 annual result came in at $303282.0, down 70.26% from the prior year.
- Inventory rose to $281462.0 in Q1 2026 per CVM's latest filing, from $230448.0 in the prior quarter.
- Over five years, Inventory peaked at $2.6 million in Q2 2024 and troughed at $230448.0 in Q4 2025.
- A 5-year average of $1.5 million and a median of $1.9 million in 2023 frame the typical range for Inventory.
- The sharpest annual moves came in 2022 and 2025: Inventory soared 37.6% in 2022, then sank 79.73% in 2025.
- Over 5 years, Inventory stood at $1.8 million in 2022, then increased by 26.96% to $2.3 million in 2023, then slumped by 63.23% to $863104.0 in 2024, then sank by 73.3% to $230448.0 in 2025, then grew by 22.14% to $281462.0 in 2026.
- According to Business Quant data, Inventory over the past three periods registered $281462.0, $230448.0, and $303282.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cel Sci | 2.12 Mn | -4.42 Mn | - | 266,763.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 281,462.00 |
| Dec 31, 2025 | 230,448.00 |
| Sep 30, 2025 | 303,282.00 |
| Jun 30, 2025 | 518,040.00 |
| Mar 31, 2025 | 882,692.00 |
| Dec 31, 2024 | 863,104.00 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 2.35 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 1.89 Mn |
| Dec 31, 2022 | 1.85 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.17 Mn |
| Mar 31, 2022 | 2.01 Mn |
| Dec 31, 2021 | 2.07 Mn |
| Sep 30, 2021 | 2.01 Mn |
| Jun 30, 2021 | 1.58 Mn |